Ensign Peak Advisors, Inc Meira G Tx Holdings PLC Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.55 - $11.25 $37,070 - $55,237	4,910 New	4,910 $41,000
Q4 2021 Feb 11, 2022	SELL	$12.78 - $23.74 $81,114 - $150,677	-6,347 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.73 - $16.08 $194,635 - $266,815	-16,593 Reduced 72.33%	6,347 $84,000
Q3 2020 Nov 12, 2020	BUY	$11.59 - $14.93 $173,815 - $223,905	14,997 Added 188.81%	22,940 $304,000
Q1 2020 May 11, 2020	SELL	$9.31 - $21.24 $83,268 - $189,970	-8,944 Reduced 52.96%	7,943 $107,000
Q4 2019 Feb 14, 2020	BUY	$13.91 - $21.48 $234,898 - $362,732	16,887 New	16,887 $338,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $288M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.